Ignite Creation Date:
2025-12-24 @ 11:47 PM
Ignite Modification Date:
2026-03-09 @ 4:05 AM
Study NCT ID:
NCT04837651
Status:
COMPLETED
Last Update Posted:
2021-08-02
First Post:
2021-03-16
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Humoral and T-Cell Responses to COVID-19 Vaccination in Multiple Sclerosis Patients Treated With Ocrelizumab Treated With Ocrelizumab or Natalizumab
Sponsor:
Dragonfly Research, LLC
Organization: